Voloridge Investment Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-145,841
| Closed | -$468K | – | 1133 |
|
|
2023
Q4 | $468K | Sell |
145,841
-254,704
| -64% | -$818K | ﹤0.01% | 1039 |
|
|
2023
Q3 | $1.27M | Sell |
400,545
-109,509
| -21% | -$347K | 0.01% | 1044 |
|
|
2023
Q2 | $2.53M | Sell |
510,054
-471,614
| -48% | -$2.34M | 0.01% | 915 |
|
|
2023
Q1 | $4.85M | Sell |
981,668
-62,663
| -6% | -$310K | 0.02% | 677 |
|
|
2022
Q4 | $6.57M | Buy |
1,044,331
+255,058
| +32% | +$1.6M | 0.04% | 559 |
|
|
2022
Q3 | $8.52M | Sell |
789,273
-54,588
| -6% | -$590K | 0.05% | 491 |
|
|
2022
Q2 | $9.62M | Buy |
843,861
+50,366
| +6% | +$574K | 0.05% | 452 |
|
|
2022
Q1 | $7.23M | Buy |
793,495
+512,109
| +182% | +$4.67M | 0.04% | 511 |
|
|
2021
Q4 | $4.2M | Buy |
+281,386
| New | +$4.2M | 0.02% | 779 |
|
|
2021
Q1 | – | Sell |
-51,091
| Closed | -$1.29M | – | 1357 |
|
|
2020
Q4 | $1.29M | Sell |
51,091
-65,254
| -56% | -$1.65M | 0.01% | 889 |
|
|
2020
Q3 | $4.39M | Sell |
116,345
-81,876
| -41% | -$3.09M | 0.04% | 479 |
|
|
2020
Q2 | $8.49M | Buy |
+198,221
| New | +$8.49M | 0.1% | 233 |
|